UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 935

Sortiert nach

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families

Orphanet journal of rare diseases, 2022-05, Vol.17 (1), p.205-205, Article 205

2022

Link zum Volltext

Verfügbarkeit prüfen

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Diabetes therapy, 2015-09, Vol.6 (3), p.303-316

2015

Link zum Volltext

Verfügbarkeit prüfen

1024-P: Technosphere Insulin Added to Basal Insulin Is Associated with Less Weight Gain than Basal Insulin plus Insulin Aspart or Insulin Analog (Aspart) 70/30 Mixture in Type 2 DM

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

137-OR: Dasiglucagon Ready-to-Use Autoinjector Is More Reliably and Quickly Administered than Glucagon Emergency Kit (GEK)

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Diabetes therapy, 2015-09, Vol.6 (3), p.317-328

2015

Link zum Volltext

Verfügbarkeit prüfen

235-OR: Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

1023-P: Dose Titration and Clinical Effects of Inhaled Technosphere Insulin Compared with Mealtime Subcutaneous (SC) Analog Insulin Therapy in Type 1 Diabetes (T1D)

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

151-OR: Technosphere Insulin Provides Better Early Postprandial Glucose Control than Subcutaneous Rapid-Acting Analog

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Current medical research and opinion, 2018-02, Vol.34 (2), p.329-336

2018

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobin [A.sub.1c] to diagnose diabetes: why the controversy over adding a new tool?

Clinical chemistry (Baltimore, Md.), 2011-02, Vol.57 (2), p.255

2011

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Diabetes care, 2006-05, Vol.29 (5), p.1016-1023

2006

Link zum Volltext

Verfügbarkeit prüfen

The Gut, Brain, and Peripheral Tissue Connection: Metabolic Disease in the Incretin Era

Endocrine practice, 2010-09, Vol.16 (2), p.33-38

Kendall, David M

2010

Link zum Volltext

Verfügbarkeit prüfen

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project

Diabetology and metabolic syndrome, 2009-09, Vol.1 (1), p.5-5, Article 5

2009

Link zum Volltext

Verfügbarkeit prüfen

Consensus report of the coalition for clinical research-self-monitoring of blood glucose

Journal of diabetes science and technology, 2008-11, Vol.2 (6), p.1030-1053

2008

Link zum Volltext

Verfügbarkeit prüfen

Burden in caregivers of Alzheimer’s disease patients with and without diabetes

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P600-P600

2015

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Diabetes therapy, 2015-12, Vol.6 (4), p.651-651

2015

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Diabetes therapy, 2015-09, Vol.6 (3), p.403-403

2015

Link zum Volltext

Verfügbarkeit prüfen

Exenatide for type 2 diabetes – Authors' reply

The Lancet (British edition), 2009, Vol.373 (9658), p.122-123

2009

Link zum Volltext

Verfügbarkeit prüfen

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

Diabetes care, 2009-05, Vol.32 (5), p.762-768

2009

Link zum Volltext

Verfügbarkeit prüfen

1350-P: Safety and Pharmacokinetics of Technosphere Insulin in Pediatric Patients

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Response to bell

Metabolic syndrome and related disorders, 2005-09, Vol.3 (3), p.202-202

Kendall, David M

2005

Link zum Volltext

Verfügbarkeit prüfen

Total and Severe Hypoglycemia Is Reduced with Use of Inhaled Technosphere Insulin (TI, Afrezza®) Relative to Insulin Aspart in Type 1 Diabetes

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined

Diabetes (New York, N.Y.), 1997-01, Vol.46 (1), p.28

1997

Link zum Volltext

Verfügbarkeit prüfen

The Truth about Lipid Effects of the Thiazolidinediones

Metabolic syndrome and related disorders, 2005, Vol.3 (3), p.194-197

Kendall, David M

2005

Link zum Volltext

Verfügbarkeit prüfen

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Bell and Brunzell

Diabetes care, 2005-12, Vol.28 (12), p.2985

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 935

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(860)
Mit Volltextzugriff
(888)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(612)
Technology
(296)
Computer Science
(279)
Computer Science, Theory & Methods
(269)
Life Sciences & Biomedicine
(263)
Computer Science, Interdisciplinary Applications
(153)
Animals
(128)
Biological And Medical Sciences
(83)
Genetic Algorithm
(67)
Male
(63)
Physical Sciences
(59)
Fundamental And Applied Biological Sciences. Psychology
(49)
Female
(47)
Medical Sciences
(40)
Rats
(40)
Neurosciences & Neurology
(36)
Environmental Sciences & Ecology
(35)
Science & Technology - Other Topics
(31)
Mice
(30)
Multidisciplinary Sciences
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

1024-P: Technosphere Insulin Added to Basal Insulin Is Associated with Less Weight Gain than Basal Insulin plus Insulin Aspart or Insulin Analog (Aspart) 70/30 Mixture in Type 2 DM

137-OR: Dasiglucagon Ready-to-Use Autoinjector Is More Reliably and Quickly Administered than Glucagon Emergency Kit (GEK)

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

235-OR: Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin

1023-P: Dose Titration and Clinical Effects of Inhaled Technosphere Insulin Compared with Mealtime Subcutaneous (SC) Analog Insulin Therapy in Type 1 Diabetes (T1D)

151-OR: Technosphere Insulin Provides Better Early Postprandial Glucose Control than Subcutaneous Rapid-Acting Analog

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Hemoglobin [A.sub.1c] to diagnose diabetes: why the controversy over adding a new tool?

Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

The Gut, Brain, and Peripheral Tissue Connection: Metabolic Disease in the Incretin Era

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project

Consensus report of the coalition for clinical research-self-monitoring of blood glucose

Burden in caregivers of Alzheimer’s disease patients with and without diabetes

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Exenatide for type 2 diabetes – Authors' reply

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

1350-P: Safety and Pharmacokinetics of Technosphere Insulin in Pediatric Patients

Response to bell

Total and Severe Hypoglycemia Is Reduced with Use of Inhaled Technosphere Insulin (TI, Afrezza®) Relative to Insulin Aspart in Type 1 Diabetes

The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined

The Truth about Lipid Effects of the Thiazolidinediones

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Bell and Brunzell

Aktive Filter

Suchergebnisse filtern